Navigation Links
TVA Medical's Minimally Invasive System for Hemodialysis Access Demonstrates Success in Clinical Study
Date:9/26/2013

AUSTIN, Texas, Sept. 26, 2013 /PRNewswire/ -- Preliminary data presented last week at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual scientific meeting demonstrated that TVA Medical's FLEX System can create vascular access for hemodialysis patients without traditional open surgery.  The technology is being studied outside of the United States and is currently not available in the U.S.  The Company intends to seek Food and Drug Administration clearance in the future.    

(Logo: http://photos.prnewswire.com/prnh/20130610/DA29604LOGO)

The study demonstrated that TVA Medical's vascular catheter-based FLEX System can create autogenous arterio-venous fistulas (AV fistulas) for hemodialysis patients with 94% procedural success. 

Surgical AV fistulas are the current gold-standard for hemodialysis access, but they are plagued by high failure rates and frequent revisions resulting in enormous healthcare costs.  Patients receiving surgical AV fistulas require an average of 2-3 additional interventions to achieve a usable fistula1, which can delay availability of the AV fistula for hemodialysis by 5-12 months2.  Additionally, 30-60% of AV fistulas are never usable for dialysis, despite numerous re-interventions.1,3,4

"The preliminary results of this first in human study demonstrate that we can create usable autogenous AV fistulas without open surgery," said Dheeraj K. Rajan, MD, an investigator of the FLEX-1 study and Head of Vascular and Interventional Radiology at University of Toronto, Canada. "Moving to an entirely percutaneous procedure for vascular access has the potential to dramatically improve patient care by improving fistula usability, reducing surgical
'/>"/>

SOURCE TVA Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Midwest Orthopaedics at Rush Minimally Invasive Spine Institute Opens Today
2. Endoscopy Devices Market to 2018 - Demand for Cost-Effective, Minimally Invasive Procedures and Reimbursement for New Indications to Increase Uptake
3. ROX Medical secures financing and achieves key milestones in providing minimally-invasive approach for treating hypertension
4. Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers
5. Apollo Hospitals Perform Revolutionary Minimally Invasive Knee Replacement (Resurfacement) Surgery
6. European Markets for Minimally Invasive Spinal Devices
7. Reimbursement Rates to Have Strong Effect on Adoption of Minimally Invasive Vertebral Compression Fracture Treatments
8. Studies Published in Pain Medicine Demonstrate Effectiveness of Minimally-Invasive Cooled Radiofrequency Treatment for Low Back Pain
9. Arthroscopy Devices Market to 2018 - Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Future Growth
10. Minimally Invasive Devices Raises $9 Million in Series B Financing to Commercialize Laparoscopic Visualization Product
11. MAQUET Medical Systems USA Launches The MIRA-i CS Retractor System For Use During Minimally Invasive Revascularization Procedures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014  Actavis plc (NYSE: ... Company has received a complete response letter from ... its New Drug Application (NDA) for the fixed-dose ... treatment of hypertension.   Photo - ... disappointed in the receipt of a complete response ...
(Date:12/24/2014)... 24, 2014 Soligenix, Inc. (OTCQB: SNGX) ... developing products that address unmet medical needs in ... today that on December 24, 2014 it closed ... The Company raised approximately $2.3 million in gross ... the net proceeds from the offering to fund ...
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, 2014 ... a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ... medical need and commercial potential, today announced that ... 2,050,000 shares of its common stock and Series ... common stock.  Funds under the management of QVT ...
Breaking Medicine Technology:Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4
(Date:12/25/2014)... December 26, 2014 The report ... to 2023” focuses on the current treatment landscape, ... the colorectal cancer market. Stivarga is a drug ... or rectal cancer. Boehringer Ingelheim is developing nintedanib ... treatment of refractory CRC in the US, Europe, ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 The ... to 2023” focuses on the current treatment landscape, unmet ... cancer market. TS-1 is an anti-cancer drug which is ... orally and is also used for treating gastric cancer ... and otastat potassium. The drug was first approved in ...
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... the 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) ... LLP reports. According to an Order issued in the ... 20th, the Court will convene an open conference on ... Building and United States Courthouse in West Palm Beach, ...
(Date:12/25/2014)... months the trends for evening dresses shift and ... of the hottest styles in the next few months.” The ... 26 A-line sweetheart evening dresses, and announces the availability of ... trying our best to help a lady to show off ... prices, we provide discounted delivery costs to our customers worldwide. ...
(Date:12/25/2014)... Recently, iFitDress.com, the popular online supplier of wedding dresses and ... of black one-shoulder cocktail dresses . In addition, all ... at discounted prices, up to 70% off. , ... weeks only. You know, we have thousands of frequent callers ... new items can visit our website for more details. The ...
Breaking Medicine News(10 mins):Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2
... a motive of enabling women the best possible avenues to ... free breast cancer screening// in Dubai, scheduled to begin next ... in the emirate, UAE nationals, expatriates and visitors, to avail ... is absolutely essential to achieve better treatment outcomes. ...
... leaders in Wales are calling on the National Assembly for ... and release// patients from a heavy financial burden. ... people to park at hospitals is an indirect tax on ... hospital clinics do so by car. Often, these people have ...
... Anti-retrovirals have always been a blessing for the HIV patients, ... double blessing; ARV’s are capable of halting// the progress of ... is well known that HIV-infection could lead to mental illness. ... to HIV. Dr Michelle Rogers, a psychiatrist, says: "There were ...
... from Bristol University has developed a technique, using luciferase, to ... in detecting// damage to heart cells after a heart attack. ... for rapid recovery from cardiac arrests and heart surgery. This ... of Biological Chemistry. ,Dr Elinor Griffiths and her ...
... published the findings of the head to head trial of ... The study was an effort in drawing a methodical comparison ... ED and diabetes, hypertension, and/or hyperlipidemia. The results showed that ... use of this drug. ,A total of 1,057 ...
... records in paper form and scattered across the offices ... need those records// most--when you're lying on a gurney ... to do. Sometimes they do the wrong thing: in ... from medical mistakes, and 1.5 million people suffer from ...
Cached Medicine News:Health News:Abolish Car Parking Charges at Welsh Hospitals, says BMA Cymru Wales 2Health News:Abolish Car Parking Charges at Welsh Hospitals, says BMA Cymru Wales 3Health News:Abolish Car Parking Charges at Welsh Hospitals, says BMA Cymru Wales 4Health News:A glowing energy measure for heart cells 2Health News:Patients suffering ED happy with Vardenafil drugs 2Health News:Dying for Data 2
This model of bench top refrigerated incubator has been designed to suit the TPS-32 platelet shaker....
ELISA for detection of Anti-Gliadin IgG....
An enzyme-linked immuno-sorbent assay for the detection and quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
Enzyme immunoassay for the quantitative determination of Gliadin-IgG antibodies in serum and plasma. This kit provides specific determination of gliadin antibodies by using highly purified gliadin....
Medicine Products: